NVCR vs. MRK
Compare and contrast key facts about NovoCure Limited (NVCR) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NVCR or MRK.
Correlation
The correlation between NVCR and MRK is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NVCR vs. MRK - Performance Comparison
Key characteristics
NVCR:
0.74
MRK:
-1.16
NVCR:
1.88
MRK:
-1.49
NVCR:
1.21
MRK:
0.79
NVCR:
0.65
MRK:
-0.85
NVCR:
2.83
MRK:
-1.79
NVCR:
21.74%
MRK:
14.65%
NVCR:
82.57%
MRK:
22.67%
NVCR:
-95.07%
MRK:
-68.62%
NVCR:
-89.51%
MRK:
-30.75%
Fundamentals
NVCR:
$2.56B
MRK:
$229.54B
NVCR:
-$1.38
MRK:
$4.78
NVCR:
-0.47
MRK:
0.07
NVCR:
$443.95M
MRK:
$48.59B
NVCR:
$340.24M
MRK:
$36.68B
NVCR:
-$97.06M
MRK:
$19.73B
Returns By Period
In the year-to-date period, NVCR achieves a -20.57% return, which is significantly lower than MRK's -8.79% return.
NVCR
-20.57%
-21.60%
21.63%
72.40%
-23.08%
N/A
MRK
-8.79%
-8.47%
-17.16%
-26.12%
5.30%
8.20%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NVCR vs. MRK — Risk-Adjusted Performance Rank
NVCR
MRK
NVCR vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for NovoCure Limited (NVCR) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NVCR vs. MRK - Dividend Comparison
NVCR has not paid dividends to shareholders, while MRK's dividend yield for the trailing twelve months is around 3.44%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVCR NovoCure Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MRK Merck & Co., Inc. | 3.44% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
Drawdowns
NVCR vs. MRK - Drawdown Comparison
The maximum NVCR drawdown since its inception was -95.07%, which is greater than MRK's maximum drawdown of -68.62%. Use the drawdown chart below to compare losses from any high point for NVCR and MRK. For additional features, visit the drawdowns tool.
Volatility
NVCR vs. MRK - Volatility Comparison
The current volatility for NovoCure Limited (NVCR) is 9.48%, while Merck & Co., Inc. (MRK) has a volatility of 11.11%. This indicates that NVCR experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NVCR vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between NovoCure Limited and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities